Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wallace Dinsmore

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of STD & AIDS|April 13, 2004
Treatment of erectile dysfunctionWallace Dinsmore
International Journal of STD & AIDS|August 24, 2013
Persistent genital arousal and restless genitalia: sexual dysfunction or subtype of vulvodynia?A R Markos, Wallace Dinsmore
BJU International|May 20, 2008
Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunctionW Wallace Dinsmore, Michael G Wyllie
BJU International|February 28, 2009
PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled studyW Wallace Dinsmore, Michael G Wyllie
Archives of Disease in Childhood. Education and Practice Edition|June 14, 2022
<i>Chlamydia trachomatis</i> conjunctivitis in the pre-pubertal childRebecca Moore, Peter Mallett, Sarah Hull, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of STD & AIDS|April 13, 2004
Treatment of erectile dysfunctionWallace Dinsmore
International Journal of STD & AIDS|August 24, 2013
Persistent genital arousal and restless genitalia: sexual dysfunction or subtype of vulvodynia?A R Markos, Wallace Dinsmore
BJU International|May 20, 2008
Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunctionW Wallace Dinsmore, Michael G Wyllie
BJU International|February 28, 2009
PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled studyW Wallace Dinsmore, Michael G Wyllie
Archives of Disease in Childhood. Education and Practice Edition|June 14, 2022
<i>Chlamydia trachomatis</i> conjunctivitis in the pre-pubertal childRebecca Moore, Peter Mallett, Sarah Hull, et al.
Pageof 1